Latest News
-

September 2026: This month in Huntington’s disease research
⏱️ 5 min read
September brought progress across the HD research landscape. From brain waves and visual thinking to DNA repeats, nutrition, inclusive care, new technologies, and encouraging SKY-0515 data, we round up a busy month in Huntington’s disease research.
-

Drug Improves Huntington’s Symptoms in Mice – and Their Offspring
⏱️ 7 min read
HD drug changes DNA folding across generations
-

mTORC1 tips the scales in Huntington’s disease mice
⏱️ 6 min read
Weighing the scales on mTORC1: A possible new target for HD therapeutics?
-

Can this synthetic oil help feed the brain in Huntington's disease?
⏱️ 6 min read
A new study shows a synthetic oil called triheptanoin changes how HD brains use energy. But will it help HD?
-

Positive results announced for re-worked tetrabenazine drug in Huntington's disease
⏱️ 8 min read
Modified 'heavy hydrogen' form of tetrabenazine appears safe and effective for chorea in Huntington's disease
-

Turning skin cells into brain cells: a Huntington's disease research breakthrough?
⏱️ 5 min read
Scientists can now change human skin cells into working neurons, like the ones that are most affected in HD.
-

Huntington's disease clinical trial announcement: huntingtin-lowering drug to enter Phase I trial in 2015
⏱️ 7 min read
A clinical trial for an exciting therapy against HD is planned for 2015. The first step is to make sure it is safe.
-

Largest creatine clinical trial for Huntington's disease halted after 'futility' analysis
⏱️ 4 min read
CREST-E, a trial of the supplement creatine, has been stopped after an early analysis found it couldn't show benefit
-

Should we worry about a huntingtin invasion?
⏱️ 5 min read
Cool lab experiments show the huntington's disease protein jumping between cells. Does this matter for HD patients?
-

EuroBuzz 2014 Video, day one
⏱️ 13 min read
Video of our first live session at the European Huntington's Disease Network Meeting.
-

EuroBuzz 2014 Video, day two
⏱️ 21 min read
Video of our second live session at the European Huntington's Disease Network Meeting.
HDBuzz Trial Tracker
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
Previously featured
-
September 2026: This month in Huntington’s disease research
-
Studying Stutters: What 900,000 genomes teach us about growing DNA repeats
-
Highlighting Mental Health Disparities in Indigenous Communities Affected by Huntington’s Disease
-
Encouraging news from Skyhawk, as SKY-0515 Phase 1/2 data continues to hold promise
-
Food for Thought: The Importance of Nutrition in Huntington’s Disease
Follow HDBuzz
Sign up to our monthly email summary by entering your email address on our mailing list page.
Suggest an article
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can’t promise to write content about any particular suggestion.
